Denileukin diftitox - DEN-i-loo-kin DIF-ti-toks is using to treat cutaneous T-cell lymphoma, a rare type of cancer that effects certain white blood cells and causes lesions to develop on the skin.
Denileukin diftitox interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be effected by the drug, other effects may also occur. Some of these may be serious and must be reported to your family doctor. Some effects may occur after treat with denileukin diftitox.
Denileukin diftitox is to be aplaying only by or under the supervision of your family doctor or other health care professional. It is available in the following dosage form - s:
Some commonly using brand names are:
In the USA
Generic name product may be available in the USA
† Not commercially available in Canada.